| Literature DB >> 29892027 |
Hojoon Park1, Pritha Verma1, Kai Hong1, Jin-Quan Yu2.
Abstract
The development of a Pd(II)-catalysed enantioselective fluorination of C(sp3)-H bonds would offer a new approach to making chiral organofluorines. However, such a strategy is particularly challenging because of the difficulty in differentiating prochiral C(sp3)-H bonds through Pd(II)-insertion, as well as the sluggish reductive elimination involving Pd-F bonds. Here, we report the development of a Pd(II)-catalysed enantioselective C(sp3)-H fluorination using a chiral transient directing group strategy. In this work, a bulky, amino amide transient directing group was developed to control the stereochemistry of the C-H insertion step and selectively promote the C(sp3)-F reductive elimination pathway from the Pd(IV)-F intermediate. Stereochemical analysis revealed that while the desired C(sp3)-F formation proceeds via an inner-sphere pathway with retention of configuration, the undesired C(sp3)-O formation occurs through an SN2-type mechanism. Elucidation of the dual mechanism allows us to rationalize the profound ligand effect on controlling reductive elimination selectivity from high-valent Pd species.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29892027 PMCID: PMC6289870 DOI: 10.1038/s41557-018-0048-1
Source DB: PubMed Journal: Nat Chem ISSN: 1755-4330 Impact factor: 24.427
Figure 1Enantioselective C(sp3)–H Fluorination
a, The possibility of multiple reductive elimination pathways from Pd(IV) species generated with [F+] as oxidant presents a challenging selectivity issue. b, This work: Pd(II)-catalyzed enantioselective C(sp3)–H fluorination using chiral transient directing group strategy. c, Profound ligand effect was observed on reductive elimination selectivity (C(sp3)–O vs. C(sp3)–F). Stereochemical analysis of products suggests that such ligand effect origins from the dual mechanism of Pd(IV) reductive elimination step.
Optimization of Reaction Conditions.a,b
|
|
Reaction conditions: substrate 1a (0.10 mmol, 1.0 equiv.), [FBF4− (0.15 mmol, 1.5 equiv.), NBu4PF6 (0.05 mmol, 0.5 equiv.), Pd(OAc)2 (10 mol%), Transient DG (20 mol%), Solvent (entry 1–4: 0.2 M, entry 5–10: 0.25 M), 70 °C, 24 h.
The yield was determined by 1H NMR analysis of the crude product using CH2Br2 as the internal standard.
5 equiv. of C6F5CO2H was used.
R = C6F5.
Figure 2Experimental evidence for the dual mechanism of Pd(IV) reductive elimination
a, Stereochemical analysis of acetoxylation & fluorination reveals opposite configuration. b, Deuterium incorporation experiments show that C(sp3)–H insertion process is irreversible under our catalytic conditions. c, Bicyclic palladacycle 8 was synthesized and characterized via X-ray crystallography. Identical stereochemical outcome was observed with the catalytic conditions when 8 was reacted with [F.
Figure 3Controlling reductive elimination pathways from putative Pd(IV) intermediates
Trends of reductive elimination selectivity observed with anionic and neutral transient directing groups.
Scope of 2-alkylbenzaldehyde substrates for Pd(II)-catalyzed enantioselective C(sp3)–H fluorination.a,b
|
|
Reaction conditions: substrate 1 (0.10 mmol, 1.0 equiv.), [FBF4− (0.15 mmol, 1.5 equiv.), NBu4PF6 (50 mol%), C6F5CO2H (0.50 mmol, 5.0 equiv.), Pd(OAc)2 (10 mol%), TDG4 (20 mol%), Benzene (0.4 mL), 70 °C, 24 h.
Isolated yield as a mixture with substrate 1 unless otherwise noted. C(sp3)–F : C(sp3)–O ratio was determined by 1H NMR analysis.
Due to the high volatility of the product, yield was determined by 1H NMR analysis.
[FPF6− (0.15 mol, 1.5 equiv.) was used instead of [FBF4−/NBu4PF6.
DCM (0.4 mL) was used as solvent.
TDG4 (25 mol%) was used.
Full table of unsuccessful substrates are shown in the Supplementary Information.
Figure 4Access to diverse chiral organofluorines
a, NaN3 (4.0 equiv.), HMPA (0.2 M), r.t., 36 h. b, piperidine (3.0 equiv.), K2CO3 (3.0 equiv.), DMF (0.2 M), 100 °C, 12 h. c, PhOH (3 equiv.), K2CO3 (3.0 equiv.), DMF (0.2 M), 100 °C, 2 h. d, NaSMe (3.0 equiv.), DMF (0.2 M), 60 °C, 4 h. e, Ethyl thioglycolate (3.0 equiv.), K2CO3 (3.0 equiv.), DMF (0.2 M), 60 °C, 3 h. f, NaN3 (3.0 equiv.), DMF (0.2 M), 100 °C, 12 h. g, guanidine carbonate (2.5 equiv.), DMA (0.2 M), 150 °C, 1 h. h, 3-amino-1,2,4-triazole (2.0 equiv.), Cs2CO3 (3.0 equiv.), DMF (0.2 M), 100 °C, 2 h.